Contact us
News

Keep you updated

with the latest info of XtalPi

Explore all resources
  • News
XtalPi Advances Global STEM Education Through AI-Powered Science Outreach
xtalpi digital chemistry solutions
  • News
XtalPi Sweeps Prestigious Awards, Earning Global Recognition for AI Innovation
  • News
XtalPi Partners with UCB to Accelerate Next-Gen Biologic Development via AI-Powered XtalFold™ Platform
  • News
XtalPi Deploys AI Peptide Platform in Landmark Cancer Collaboration with Singapore Research Consortium
  • News
XtalPi Wins Prestigious ESG Honor at 2024 Hong Kong Corporate Governance Awards
  • News
Dr. Ma Jian Honored with 2024 EY Entrepreneur Of The Year Award
  • News
XtalPi Crowned Champion at Global Crystal Structure Prediction Challenge
hit discovery
  • News
XtalPi Joins Forces with Microsoft China to Pioneer AI-Driven Breakthroughs in Life Sciences and Beyond
  • News
XtalPi Licenses XtalFold™ AI Platform to Janssen Biotech for Next-Gen Biologics Discovery
About XtalPi, a pioneering AI drug discovery company
  • News
MIT and XtalPi Forge Partnership to Pioneer AI-Driven Scientific Discovery
  • News
Dr. Wen Shuhao Appointed to MIT Visiting Committee, Becoming Youngest Member in Chemistry Division
hit discovery
  • News
XtalPi’s AI Platform Validated as Partner Companies Secure IND Approvals and Major Funding
  • News
XtalPi Debuts on HKEX Main Board as First 18C Listing, Pioneering AI + Robotics Innovation
XtalGazer | Advanced Solid State Research for Drug Discovery
  • News
XtalPi Launches XtalGazer™: Revolutionizing Drug Crystallization with AI-Driven Precision
  • News
Dr. Ma Jian Meets Hong Kong Chief Executive John Lee, Signs MoU with Hetao Shenzhen-Hong Kong Innovation Cooperation Zone
  • News
Singapore Deputy Prime Minister Heng Swee Keat Visits XtalPi, Commends AI-Driven Innovations
  • News
XtalPi Chairman Highlights AI as Foundational Infrastructure at Fortune Innovation Forum
  • News
XtalPi Announces Collaboration with Lilly, Using AI + Robotics to Uncover First-in-class Therapeutics
  • News
XtalPi Names New COO for U.S. Operations, Bringing Its Autonomous Labs to Boston in Continued Global Expansion
  • News
XtalPi Announces Research Collaboration with Janssen
  • News
Fierce Medtech names XtalPi as one of its “Fierce 15” Med Tech Companies of 2021
  • News
Research Collaboration between XtalPi Inc and Acerand Therapeutics to develop potential novel anti-cancer therapies using High-precision Physics-based model and Machine Learning
  • News
XtalPi and Signet Expand AI Drug Discovery Collaboration to Novel Cancer Target

XtalPi uses AI, quantum physics, and automation to speed up drug discovery and materials research. They provide integrated solutions to streamline R&D processes, reducing time and waste in developing new therapies.

© 2025 All Rights Reserved, Privacy Policy
Sign up for our newsletter

Search XtalPi

  • Publications, Solid State Research
Templated Nucleation of Clotrimazole and Ketoprofen on Polymer Substrates
  • Publications, Solid State Research
Tale of Two Polymorphs: Investigating the Structural Differences and Dynamic Relationship between Nirmatrelvir Solid Forms (Paxlovid)
  • Publications, Solid State Research
Cocrystal Synthesis through Crystal Structure Prediction
  • Software
PatSight Patent Extraction tool
XFEP High Accuracy Free Energy Calculation Tool
XMolGen Generative Chemistry Tool
  • Drug Discovery
Hit Discovery
Hit or Lead Optimization
Biology Capabilities
  • Discovery Chemistry
Automation-aided Chemical Synthesis
Focused Library
Building Blocks
  • Solid State Research
XtalGazer™Solid State Research Solution
Experimental Solid-State R&D
Solid-State Chemistry Computational Solutions
Crystal Structure Determination
Get started

XtalPi Newsletter